CONTEXT: It is unclear whether adipocyte size or body fat distribution is most strongly linked to the metabolic complications of obesity. OBJECTIVE: Our objective was to test whether adipocyte size better predicts metabolic characteristics of obesity than body composition. DESIGN, PARTICIPANTS, AND SETTING: We analyzed the relationship between metabolic and anthropometric data collected from 432 largely Caucasian research volunteers (264 women) participating in studies conducted in the Mayo General Clinical Research Center between 1995 and 2008. MAIN OUTCOME MEASURES: Metabolic variables included fasting plasma glucose, insulin, and triglyceride concentrations. Anthropometric variables included body composition, fat distribution, and sc abdominal and femoral adipocyte size. RESULTS: Using both univariate and multivariate regression analysis, fasting triglyceride in both men and women was best predicted by computed tomography of visceral fat area. Fasting insulin concentrations were best predicted by sc abdominal fat area in women (r(2) = 0.40; P < 0.01) and body mass index in men (r(2) = 0.53; P < 0.0001); adipocyte size did not contribute independently. In men, fasting glucose concentrations were predicted by femoral adipocyte size (partial r(2) = 0.07; P = 0.002), body mass index (partial r(2) = 0.03; P = 0.07), and age (partial r(2) = 0.02; P = 0.06). In women, fasting glucose was predicted by abdominal sc fat area (partial r(2) = 0.12; P < 0.0001) and age (partial r(2) = 0.03; P = 0.01). CONCLUSIONS: Our hypothesis that adipocyte size is the best predictor of metabolic characteristics was not supported in this population. The alternative explanation is that fat mass and body fat distribution have more influence on metabolic responses than adipocyte size.
CONTEXT: It is unclear whether adipocyte size or body fat distribution is most strongly linked to the metabolic complications of obesity. OBJECTIVE: Our objective was to test whether adipocyte size better predicts metabolic characteristics of obesity than body composition. DESIGN, PARTICIPANTS, AND SETTING: We analyzed the relationship between metabolic and anthropometric data collected from 432 largely Caucasian research volunteers (264 women) participating in studies conducted in the Mayo General Clinical Research Center between 1995 and 2008. MAIN OUTCOME MEASURES: Metabolic variables included fasting plasma glucose, insulin, and triglyceride concentrations. Anthropometric variables included body composition, fat distribution, and sc abdominal and femoral adipocyte size. RESULTS: Using both univariate and multivariate regression analysis, fasting triglyceride in both men and women was best predicted by computed tomography of visceral fat area. Fasting insulin concentrations were best predicted by sc abdominal fat area in women (r(2) = 0.40; P < 0.01) and body mass index in men (r(2) = 0.53; P < 0.0001); adipocyte size did not contribute independently. In men, fasting glucose concentrations were predicted by femoral adipocyte size (partial r(2) = 0.07; P = 0.002), body mass index (partial r(2) = 0.03; P = 0.07), and age (partial r(2) = 0.02; P = 0.06). In women, fasting glucose was predicted by abdominal sc fat area (partial r(2) = 0.12; P < 0.0001) and age (partial r(2) = 0.03; P = 0.01). CONCLUSIONS: Our hypothesis that adipocyte size is the best predictor of metabolic characteristics was not supported in this population. The alternative explanation is that fat mass and body fat distribution have more influence on metabolic responses than adipocyte size.
Authors: Samyah Shadid; Jill A Kanaley; Michael T Sheehan; Michael D Jensen Journal: Am J Physiol Endocrinol Metab Date: 2007-02-13 Impact factor: 4.310
Authors: Caroline S Fox; Joseph M Massaro; Udo Hoffmann; Karla M Pou; Pal Maurovich-Horvat; Chun-Yu Liu; Ramachandran S Vasan; Joanne M Murabito; James B Meigs; L Adrienne Cupples; Ralph B D'Agostino; Christopher J O'Donnell Journal: Circulation Date: 2007-06-18 Impact factor: 29.690
Authors: Yourka D Tchoukalova; Christina Koutsari; Maksym V Karpyak; Susanne B Votruba; Eliana Wendland; Michael D Jensen Journal: Am J Clin Nutr Date: 2008-01 Impact factor: 7.045
Authors: T Pischon; H Boeing; K Hoffmann; M Bergmann; M B Schulze; K Overvad; Y T van der Schouw; E Spencer; K G M Moons; A Tjønneland; J Halkjaer; M K Jensen; J Stegger; F Clavel-Chapelon; M-C Boutron-Ruault; V Chajes; J Linseisen; R Kaaks; A Trichopoulou; D Trichopoulos; C Bamia; S Sieri; D Palli; R Tumino; P Vineis; S Panico; P H M Peeters; A M May; H B Bueno-de-Mesquita; F J B van Duijnhoven; G Hallmans; L Weinehall; J Manjer; B Hedblad; E Lund; A Agudo; L Arriola; A Barricarte; C Navarro; C Martinez; J R Quirós; T Key; S Bingham; K T Khaw; P Boffetta; M Jenab; P Ferrari; E Riboli Journal: N Engl J Med Date: 2008-11-13 Impact factor: 91.245
Authors: Lawrence G Kettwich; Wilmer L Sibbitt; N Suzanne Emil; Usman Ashraf; Leslie Sanchez-Goettler; Yumna Thariani; Arthur D Bankhurst Journal: Amyloid Date: 2012-03-27 Impact factor: 7.141
Authors: Hawley E Kunz; Corey R Hart; Kevin J Gries; Mojtaba Parvizi; Marcello Laurenti; Chiara Dalla Man; Natalie Moore; Xiaoyan Zhang; Zachary Ryan; Eric C Polley; Michael D Jensen; Adrian Vella; Ian R Lanza Journal: Am J Physiol Endocrinol Metab Date: 2021-05-17 Impact factor: 4.310